Iradimed (IRMD) Revenue Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.96% |
| Dec 31, 2025 | 21.57% |
| Sep 30, 2025 | 22.46% |
| Jun 30, 2025 | 24.60% |
| Mar 31, 2025 | 17.59% |
| Dec 31, 2024 | 12.23% |
| Sep 30, 2024 | 12.96% |
| Jun 30, 2024 | 14.21% |
| Mar 31, 2024 | 15.84% |
| Dec 31, 2023 | 15.92% |
| Sep 30, 2023 | 16.73% |
| Jun 30, 2023 | 16.94% |
| Mar 31, 2023 | 16.84% |
| Dec 31, 2022 | 17.26% |
| Sep 30, 2022 | 18.70% |
| Jun 30, 2022 | 18.15% |
| Mar 31, 2022 | 18.98% |
| Dec 31, 2021 | 14.66% |
| Sep 30, 2021 | 7.29% |
| Jun 30, 2021 | -0.12% |
| Mar 31, 2021 | 0.57% |
| Dec 31, 2020 | -0.58% |
| Sep 30, 2020 | -1.24% |
| Jun 30, 2020 | -2.24% |
| Mar 31, 2020 | 4.41% |
| Dec 31, 2019 | 24.90% |
| Sep 30, 2019 | 21.19% |
| Jun 30, 2019 | 14.44% |
| Mar 31, 2019 | 18.86% |
| Dec 31, 2018 | 19.26% |
| Sep 30, 2018 | 25.16% |
| Jun 30, 2018 | 21.60% |